Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-01

Clinical Trial Update: A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY900014 in participants with Type 1 diabetes using an insulin pump has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY900014

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2020-05-01